Biotech

All Articles

Vaderis' unusual blood vessel disorder drug reduces nosebleeds

.Vaderis Therapeutics' goal to develop the first drug intended specifically at a particular uncommon...

Navigator rears $100M to establish new autoimmune pipe

.Navigator Medicines has actually outfitted on its own along with $100 thousand in series A funds as...

Duality looks for cash money for ADC trials as IPO surge infects Asia

.China's Duplicity Biotherapeutics has filed (PDF) paperwork for a Hong Kong IPO, finding an unrevea...

YolTech markets China rights to genetics editing and enhancing treatment for $29M

.4 months after Mandarin gene editing and enhancing firm YolTech Rehabs took its own cholesterol lev...

Addex stock climbs after Indivior provides to $300M for material

.Indivior is actually picking up a tiny particle allosteric modulator created to address drug make u...

Molecular Allies changes AML trial over 'suboptimal visibility'

.Molecular Companions has identified "suboptimal exposure" to its tetra-specific T-cell engager as t...

Despite mixed market, a venture capital rebirth could be can be found in Europe: PitchBook

.While the biotech assets performance in Europe has slowed down rather complying with a COVID-19 bac...

8 months after a $213M fundraise, genetics editor Volume creates cuts

.After raising $213 million in 2023-- some of the year's biggest personal biotech shots-- Volume Bio...

BioMarin creates officer team along with biotech veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, shootings as ...

Biopharma Q2 VC struck highest level since '22, while M&ampA reduced

.Financial backing funding in to biopharma cheered $9.2 billion across 215 sell the second fourth of...